Technion to award Pfizer CEO honorary doctorate for coronavirus vaccine
Technion to award Pfizer CEO honorary doctorate for coronavirus vaccine
“This is an emotional closure for me,” says Albert Bourla, the son of Holocaust survivors from Thessaloniki.
Pfizer CEO Albert Bourla. Source: Twitter.
Spread the word.
(February 3, 2021 / Israel Hayom) The Technion-Israel Institute of Technology will award an honorary doctorate to Pfizer CEO and chairman Dr. Albert Bourla for his “extraordinary achievement” in leading the record-time development of a vaccine against SARS-CoV-2, Technion president Professor Uri Sivan announced this month.
“Dr. Bourla headed the trailblazing effort to develop a vaccine against the coronavirus,” said Sivan. “In his 27 years with Pfizer, Dr. Bourla promoted multiple areas within the company, among them technological innovation,” said Sivan. “[His] family history, as a son of Holocaust survivors from Thessaloniki, is a symbol of the remark